{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"BioBreakthroughs","title":"#38 - Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/74ad9185\"></iframe>","width":"100%","height":180,"duration":1322,"description":"Join us on the latest episode! Our Guest: Dr. Michael Kyle, SVP & Chief Medical Officer at Currax Pharmaceuticals.\nWhat you'll get out of this episode:\nDr. Michael Kyle's Background: Insights into his journey from medical practice to becoming SVP & Chief Medical Officer of Currax Pharmaceuticals.\nUnderstanding Obesity: A discussion on different types of obesity and the importance of tailored treatments.\nGlobal Perspectives: Comparing how the U.S. and European countries handle obesity and the lessons to be learned.\nEvolving Treatments: The parallel evolution of hypertension and obesity treatments.\nBehavioral Approaches: The importance of sustainable lifestyle changes and behavior modification in addressing obesity.\n\nTo learn more about our guests and their companies:\nLinkedIn https://www.linkedin.com/in/michael-l-kyle/\nCompany LinkedIn https://www.linkedin.com/company/currax-pharmaceuticals-llc/\nWebsite https://www.curraxpharma.com/\n\nOur sponsor for this episode are:\nSage Growth Partners https://sage-growth.com/\nBioBreakthroughs is part of the Slice of Healthcare podcast network:\nLinkedIn: https://www.linkedin.com/company/sliceofhealthcare/","thumbnail_url":"https://img.transistorcdn.com/roxGfgcNItysBs3fg55SsdSx4l_Pbz86Ktm2KMDYkR4/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzQwNjg1LzE2ODE5/MzQxODQtYXJ0d29y/ay5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}